{
DexCom, Inc.

Companies

}
001122334455554433221100
001122334455554433221100
Symbol DXCM
Name DexCom, Inc.
Currency USD
Sector Health Care
IndustryGroup Pharmaceuticals, Biotechnology & Life Sciences
Industry Biotechnology
Market NASDAQ Global Select
Country United States
State CA
City San Diego
Zipcode 92121
Website http://www.dexcom.com
Track all markets on TradingView

ubs initiates buy rating for penumbra with strong revenue growth forecast

UBS has initiated coverage on Penumbra with a Buy rating and a price target of $305, citing a projected 14% revenue CAGR through 2029, driven by a strong product launch cycle and growth in the venous thromboembolism market. The stock, currently trading at $263.69, is expected to maintain a premium valuation in the high-growth MedTech sector, supported by a gross profit margin of 63% and a 17% revenue growth over the past year. Other analysts, including Oppenheimer and Wells Fargo, have also expressed positive outlooks on Penumbra, anticipating continued double-digit growth and successful product introductions.
in.investing.com
Abbott Laboratories EDWARDS LIFESCIENCES BOSTON SCIENTIFIC Intuitive Surgical, Inc. Inari Medical Inc Medtronic plc DexCom, Inc. Penumbra, Inc. Stryker Corporation USA Joe Biden Matthew Blackman Show more
Business & Industry, Market Report
11:02 21.01.2025

Dow Jones rises as American Airlines flights grounded during holiday rush

The stock market saw gains during the Christmas Eve trading session, with the Dow Jones rising over 175 points and the Nasdaq composite up 0.9%. Adtalem Global Education and Fortinet are nearing buy points, while American Airlines faced a temporary grounding of flights due to a technical issue. Major tech stocks like Nvidia and Amazon also showed strength, contributing to the overall positive market sentiment.
Investor's Business Daily
MicroStrategy Incorporated Moderna, Inc. Amazon.com, Inc. Ralph Lauren Corp Blackstone Inc. Tesla, Inc. Adtalem Global Education Inc. NVIDIA Corporation UnitedHealth Group Inc AMERICAN AIRLINES GROUP Fortinet, Inc. DexCom, Inc. Palantir Technologies Inc. USA Michael Larkin Show more
Finance & Economy, Market Report
16:48 24.12.2024

Top Healthcare Stocks to Consider for Long-Term Investment Success

DexCom and Intuitive Surgical are two healthcare stocks poised for significant growth over the next decade. DexCom, despite recent challenges, is expanding its continuous glucose monitoring systems and building a network effect that enhances its market position. Meanwhile, Intuitive Surgical continues to lead in robotic-assisted surgery, recently advancing its da Vinci system with FDA clearance for its fifth generation, underscoring its commitment to innovation.
Yahoo Finance
DexCom, Inc. Intuitive Surgical, Inc. USA
Healthcare, Market Report
13:45 28.11.2024

healthcare consumables market poised for rapid growth driven by sustainability trends

The healthcare consumables market is projected to grow from $281.63 billion in 2023 to $466.65 billion by 2028, driven by rising hospital admissions, chronic disease prevalence, and the adoption of biodegradable products. Major players are focusing on eco-friendly innovations to enhance sustainability and meet increasing healthcare demands.
openPR.com
Nipro Corporation Medi-Plast Ltd. Fresenius Kabi AG Smith & Nephew plc Alcon Laboratories Inc. B. Braun Melsungen AG Zimmer Biomet Holdings, Inc. Invacare Corporation BioLife Solutions, Inc. Boston Scientific Corporation Johnson & Johnson Siemens Healthineers AG Abbott Laboratories Cardinal Health, Inc. GE HealthCare Technologies Inc. Coloplast A/S Philips Healthcare DexCom, Inc. Ortho-Clinical Diagnostics Inc. Terumo Corporation AngioDynamics, Inc. Becton Dickinson and Company (BD) Stryker Corporation Hollister Incorporated Hologic, Inc. 3M Company Brian Johnson Show more
Healthcare, Market Report
11:38 28.11.2024

mobile healthcare market projected to reach 380 billion by 2028

The mobile healthcare market is projected to grow from $105.73 billion in 2023 to $137.12 billion in 2024, with a CAGR of 29.7%, driven by the rising prevalence of chronic diseases and advancements in telehealth. By 2028, the market is expected to reach $380.8 billion, reflecting ongoing innovations and integration of technology in healthcare. Key trends include telehealth adoption, wearable technology, and a focus on health equity.
openPR.com
United States Dollar Livongo Health Inc. Zocdoc Inc. AT&T Inc. Omada Health Inc. Ready Inc. VillageMD LLC DexCom, Inc. K Health Inc. Iora Health Inc. Lemonaid Health Inc. SoftServe Inc. 98point6 Inc. iHealth Labs Inc. Masimo Corporation Doctor on Demand Inc. Vodafone Group Public Limited Company Medici Technologies Inc. OMRON Corporation HealthTap Inc. NIKE, Inc. Cityblock Health Inc. MediciNova, Inc. Withings S. A. Teladoc Health, Inc. ChenMed LLC Athenahealth Inc. Carbon Health Inc. AliveCor Inc. Koninklijke Philips N.V. Amwell Inc. Ginger. io Inc. Oak Street Health Inc. DispatchHealth Inc. HIMS & HERS HEALTH INC Apple Inc. Google LLC One Medical Group Inc. Qualcomm Technologies Inc. Telefónica, S.A. Samsung Electronics Co. Ltd. Forward Health Inc. Biotelemetry Inc. Show more
Healthcare, Market Report
06:25 26.11.2024

hi-tech medical devices market poised for growth driven by innovation and sustainability

The global Hi-Tech Medical Devices Market is experiencing significant growth driven by technological advancements, changing consumer preferences, and a focus on sustainability. Key objectives include forecasting market size across regions, analyzing growth factors, and identifying opportunities for stakeholders. Major players in the market include Medtronic, Abbott Laboratories, and Johnson & Johnson, with a comprehensive analysis of competitive dynamics and market trends provided in the research report.
openPR.com
Medtronic Johnson & Johnson Philips Healthcare Siemens Healthineers AG Baxter International Inc. Abbott Laboratories Edwards Lifesciences Corporation Hologic, Inc. DexCom, Inc. Fresenius Medical Care AG Thermo Fisher Scientific Inc. Becton, Dickinson and Company Varian Medical Systems Boston Scientific Corporation Zimmer Biomet Holdings, Inc. Intuitive Surgical, Inc. Illumina, Inc. St. Jude Medical, Atrial Fibrillation Division Inc. Stryker Corporation GE HealthCare Technologies Inc. USA DEU ITA MEX ARG AUS ZAF IND SAU RUS JPN KOR BRA CAN ARE ESP CHN Brian Johnson Jeff Stryker Show more
Technology & Innovation, Market Report
05:10 26.11.2024

ura and dexcom partner to enhance metabolic health tracking for users

Eli Lilly"s experimental cholesterol pill, muvalaplin, has shown promising results in a mid-stage trial, significantly reducing levels of lipoprotein(a), a genetic risk factor for heart disease. The highest dose decreased Lp(a) by 70% compared to placebo, with a favorable safety profile. Analysts suggest the drug could become a blockbuster if it proves effective in preventing cardiovascular events in future trials.
CNBC
Novartis AG DexCom, Inc. Veritone, Inc. Eli Lilly and Company Oura USA Matt Dolan Ruth Gimeno Annika Constantino David Risinger Tom Hale Show more
Healthcare, News Article
22:04 19.11.2024

Dexcom invests 75 million in Oura to enhance health monitoring technology

Dexcom has invested $75 million in Oura, the maker of the Oura Ring, to form a health monitoring partnership that aims to integrate continuous glucose monitoring with biometric data. The collaboration will enhance user health insights and includes plans for co-marketing and cross-selling products, with the first app integration expected in early 2025. This partnership allows Dexcom to expand its reach beyond prescription markets by combining its OTC glucose biosensor with the Oura Ring.
MassDevice
United States Dollar DexCom, Inc. Oura USA
Finance & Economy, News Article
18:03 19.11.2024

ura secures 75 million investment from dexcom raising valuation to 5 billion

Oura has secured a $75 million investment from Dexcom, boosting its valuation to over $5 billion. This partnership will integrate Oura rings with Dexcom's glucose monitoring technology, enabling users to track how food impacts their health. The first app integration is set to launch in early 2025, with both companies planning to co-market their products.
TechCrunch
United States Dollar Oura DexCom, Inc. Apple Inc. Matt Dolan Tom Hales Show more
Finance & Economy, News Article
15:57 19.11.2024

ura valued at five billion in investment from dexcom

Oura Health Oy has secured a $75 million investment from Dexcom Inc., a medical device company, as part of a Series D financing round. This investment values Oura at over $5 billion, a significant increase from its $2.6 billion valuation in 2022. The partnership aims to facilitate data sharing and cross-selling of products between the two firms.
bloomberg.com
United States Dollar DexCom, Inc. Oura Health Oy FIN
Finance & Economy, Press Release
12:00 19.11.2024
Trending
Subcategory
Stock Market Updates Corporate News Industry Trends Global Trade Developments Global Financial Events Central Bank Actions Banking Regulations Retail and Consumer Goods Finance Mergers & Acquisitions Industry Mergers & Acquisitions Startups & Entrepreneurship Inflation and Monetary Impact Government Economic Policies Domestic Politics CEO Changes Market Analysis and Predictions Workplace Trends Government Policies Supply Chain Management Financial Scams and Security
Countries:
USA CHN GBR CHE DEU IND FRA JPN CAN VNM AUS MEX ITA ARE SGP ESP THA TWN NLD MYS
Companies:
Tesla, Inc. Apple Inc. Barclays PLC JPMorgan Chase & Co. Deutsche Bank Money Market PP Credit Suisse Strategic Income I The Goldman Sachs Group, Inc. Berkshire Hathaway Inc. UBS Group AG BNP Paribas SA Banco Santander, S.A. Lloyds Banking Group plc SpaceXCoin USD Jenoptik AG Air France-KLM Bank of America Corporation Amazon.com, Inc. NVIDIA Corporation Infineon Technologies AG Banco BPM S.p.A.
Currencies:
United States Dollar Euro British Pound Sterling Swiss Franc Japanese Yen Indian Rupee Chinese Yuan Canadian Dollar Vietnamese Đồng South Korean Won Australian Dollar Thai Baht Singapore Dollar Indonesian Rupiah Mexican Peso Hong Kong Dollar Offshore Chinese Yuan New Zealand Dollar Cambodian Riel Myanmar Kyat
People:
Donald Trump Elon Musk JD Vance Sergio Ermotti Warren Buffett Mark Haefele Jennifer Piepszak Ursula von der Leyen Olivier Calvet Scott Bessent George Saravelos Karoline Leavitt Francois Xavier Bouvignies Joseph Spak Robin Leopold Susan P. Crawford Greg Rubini Narendra Modi Joe Biden Petra Kaltenbach

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.